Section Arrow
KALV.NASDAQ
- KalVista Pharmaceuticals
Quotes are at least 15-min delayed:2024/10/31 18:35 EDT
Last
 10.28
-0.92 (-8.21%)
Day High 
11.42 
Prev. Close
11.2 
1-M High
12.52 
Volume 
493.17K 
Bid
4.13
Ask
11.24
Day Low
10.01 
Open
11.16 
1-M Low
10.84 
Market Cap 
484.01M 
Currency USD 
P/E -- 
%Yield 2.05 
10-SMA 12.01 
20-SMA 11.77 
50-SMA 11.67 
52-W High 16.88 
52-W Low 7.21 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.57/-2.08
Enterprise Value
490.03M
Balance Sheet
Book Value Per Share
4.00
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.09
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABElevai Labs0.059-0.0339-36.49%-- 
AVTEAerovate Therapeutics2.46+0.27+12.33%-- 
ENSCEnsysce Biosciences0.5754-0.0629-9.85%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.1445-0.0099-6.41%-- 
GLYCGlycoMimetics0.4069-0.0496-10.87%-- 
Quotes are at least 15-min delayed:2024/10/31 18:35 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.